We are live on ! Find out more
CCC

Chelsea Counsel Company Portfolio holdings

AUM $236M
1-Year Est. Return 51.76%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+51.76%
3 Year Est. Return
+106.38%
5 Year Est. Return
+132.3%
10 Year Est. Return
+407.64%
AUM
$512M
AUM Growth
+$19.9M
Cap. Flow
-$12.8M
Cap. Flow %
-2.51%
Top 10 Hldgs %
34.55%
Holding
137
New
12
Increased
33
Reduced
43
Closed
8

Sector Composition

Rank Sector Weight
1 Energy 25.75%
2 Industrials 20.16%
3 Healthcare 10.09%
4 Communication Services 9.51%
5 Consumer Staples 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
76
Biogen
BIIB
$31.9B
$512K 0.1%
+1,623
New +$488K
VTR icon
77
Ventas
VTR
$45.4B
$497K 0.1%
6,792
NOV icon
78
NOV
NOV
$7.48B
$481K 0.09%
5,835
-3,076
-35% -$229K
SRE icon
79
Sempra
SRE
$53.1B
$477K 0.09%
9,110
MCK icon
80
McKesson
MCK
$105B
$466K 0.09%
2,500
+100
+4% +$17.8K
PEP icon
81
PepsiCo
PEP
$185B
$463K 0.09%
5,180
-2,000
-28% -$173K
BAC icon
82
Bank of America
BAC
$416B
$437K 0.09%
28,425
-4,600
-14% -$71.4K
V icon
83
Visa
V
$701B
$421K 0.08%
8,000
+4,000
+100% +$209K
GTU
84
DELISTED
CENTRAL GOLD TR (CANADA)
GTU
$418K 0.08%
8,810
-1,100
-11% -$50.3K
CW icon
85
Curtiss-Wright
CW
$20.8B
$394K 0.08%
6,016
GS icon
86
Goldman Sachs
GS
$284B
$385K 0.08%
2,300
WTRG icon
87
Essential Utilities
WTRG
$11.8B
$376K 0.07%
14,338
LMT icon
88
Lockheed Martin
LMT
$123B
$360K 0.07%
2,240
+500
+29% +$81.3K
WFC icon
89
Wells Fargo
WFC
$271B
$359K 0.07%
6,834
APA icon
90
APA Corp
APA
$16.6B
$352K 0.07%
3,500
-500
-13% -$45.3K
BUD icon
91
AB InBev
BUD
$156B
$345K 0.07%
+3,000
New +$330K
VMRK
92
Vivmark Residential
VMRK
$50.8B
$340K 0.07%
+5,400
New +$328K
GILD icon
93
Gilead Sciences
GILD
$181B
$339K 0.07%
4,094
-200
-5% -$15.6K
MCY icon
94
Mercury Insurance
MCY
$5.68B
$332K 0.06%
7,050
+300
+4% +$14.1K
OXY icon
95
Occidental Petroleum
OXY
$63.5B
$330K 0.06%
3,357
-313
-9% -$29.4K
DHC
96
Diversified Healthcare Trust
DHC
$1.89B
$304K 0.06%
12,613
-16,664
-57% -$389K
BP icon
97
BP
BP
$121B
$293K 0.06%
6,785
BRK.B icon
98
Berkshire Hathaway Class B
BRK.B
$1.11T
$285K 0.06%
2,249
ECL icon
99
Ecolab
ECL
$77B
$278K 0.05%
2,500
PFE icon
100
Pfizer
PFE
$157B
$264K 0.05%
9,382
-1,038
-10% -$29.6K

Similar funds

Chelsea Counsel Company's Q2 2014 Portfolio in Review

As of Q2 2014, Chelsea Counsel Company held 137 positions worth $512M, up 4% from $492M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Chelsea Counsel Company's Q2 2014 filing shows 12 new, 33 increased, 43 reduced and 8 closed positions. Its largest new stake was Biogen: 1,623 shares worth $512K. The largest sale was Unilever NV New York Registry Shares, an estimated $7.75M.

By sector, the portfolio is most concentrated in Energy at 26% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Chelsea Counsel Company's largest Q2 2014 buy was Biogen: 1,623 shares worth $512K.
  • Chelsea Counsel Company added most to Plains All American Pipeline in Q2 2014, an estimated $1.65M increase.
  • Chelsea Counsel Company's biggest Q2 2014 reduction was Unilever NV New York Registry Shares, cutting an estimated $7.75M.
  • Chelsea Counsel Company fully exited Celgene Corp in Q2 2014, selling an estimated $670K.
  • Chelsea Counsel Company's ten largest holdings make up 35% of its $512M portfolio in Q2 2014.
  • Chelsea Counsel Company opened 12 new positions and closed 8 in Q2 2014.
  • Chelsea Counsel Company's portfolio value rose 4% quarter-over-quarter to $512M.

Based on Chelsea Counsel Company's 13F filing for Q2 2014, filed 4 Sep 2014.